Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://safiyabgym507623.bloggerbags.com/46248261/tirzepatide-a-new-frontier-in-diabetes-treatment